Quality Assistance is a leading European CRO exclusively dedicated to analytical sciencesfor the development of innovative medicines. Founded in 1982 and headquartered in Belgium, the company provides a comprehensive portfolio of analytical services fully compliant with both EMA and FDA requirements, supporting drug development through regulatory submission. Operating from a single, fully integrated site, Quality Assistance offers access to a broad range of state-of-the-art analytical technologies and works in strict accordance with international standards and guidelines (GMP, GLP, GcLP/GCP, ICH, Ph. Eur., and USP). This dual EMA/FDA compliance enables clients to confidently advance their programs across European and U.S. markets. Quality Assistance has strong expertise in biotherapeutics and complex modalities, including monoclonal antibodies, antibody-drug conjugates (ADCs), proteins, peptides, oligonucleotides, mRNA, viral vectors, nanomedicines, and cell and gene therapies. Tailored analytical strategies are developed to assess quality, safety, and efficacy at every stage of the product lifecycle. Quality Assistance acts as a long-term scientific partner and has contributed to the development of more than 2,000 innovative drug candidates, many of which have reached the market.